Invesaro

Stocks Consumer discretionary POM

NASDAQ · Consumer discretionary

POMDOCTOR Ltd (POM)

POMDOCTOR Ltd reported revenue of $57.2M in fiscal 2025. It posted a net loss of $30.4M. In fiscal 2025 capital spending exceeded operating cash flow by $21.4M. At December 31, 2025 it held $1.4M in cash against $11.7M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on May 14, 2026.

Free, no password. An email when POM files with the SEC.

Price
$1.61
+0.63% on the day · November 11, 2026
52-week range $0.43 to $102.42
Market cap
$12M
Revenue (FY2025)
$57.2M
Net margin
-53.2%

Key facts about POMDOCTOR Ltd

Net worth
POMDOCTOR Ltd has a market value (market cap) of $12M at the latest share price, and shareholders' equity of -$64.9M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $57.2M, with a net loss of $30.4M.
Cash flow
In fiscal 2025 operations used $21.2M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on May 14, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What POMDOCTOR Ltd does

POMDOCTOR Ltd is registered with the SEC under industry code SIC 5900 (Retail-Miscellaneous Retail). Its shares trade on NASDAQ under the ticker POM.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$57.2M-$17M-$30.4M-$3.14-$21.4M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where POM ranks in Consumer discretionary

Revenue$57.2M
#800 of 1077 in Consumer discretionary · Bottom 26%
Net margin-53.2%
#913 of 968 in Consumer discretionary · Bottom 6%
Free cash flow margin-37.4%
#818 of 853 in Consumer discretionary · Bottom 4%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What POMDOCTOR Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 2, 2026
  2. September 30, 2026
  3. September 29, 2026
  4. September 24, 2026
  5. September 10, 2026
  6. September 4, 2026
  7. August 27, 2026
  8. August 10, 2026
  9. August 3, 2026
  10. July 28, 2026

Recent insider filings (Forms 3, 4 and 144): 7, the latest on April 30, 2026. Insider transactions on SEC

Insider trades

What the people running POMDOCTOR Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about POM

What does POMDOCTOR Ltd do?

POMDOCTOR Ltd is a company in the Consumer discretionary sector, listed on NASDAQ as POM. Its shares trade on NASDAQ under the ticker POM.

What is POMDOCTOR Ltd's net worth?

POMDOCTOR Ltd has a market value (market cap) of $12M at the latest share price, and shareholders' equity of -$64.9M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is POMDOCTOR Ltd profitable?

No. In fiscal 2025 it reported a net loss of $30.4M on revenue of $57.2M.

How much revenue does POMDOCTOR Ltd make?

In fiscal 2025 POMDOCTOR Ltd reported revenue of $57.2M.

When did POMDOCTOR Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on May 14, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from October 2, 2026.

Similar companies

Compare POM with

Compare POM with any company

Follow POM

Get an email when POMDOCTOR Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when POM files with the SEC.

Where the numbers come from

Financial figures are the values POMDOCTOR Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.